Latest Kaiser Health News Stories
As the number of people who inject drugs has soared, the rate of hepatitis C infection has climbed steeply, too, because the disease can be tied to sharing needles. Yet many drug patients are not checked for the virus that can damage the liver.
Hospital visits related to amphetamine use have spiked, with the biggest jumps in the West, new research shows. Experts say more attention needs be paid to the resurgence of methamphetamine.
For mothers in recovery from opioid addiction, narcotic pain relief during and after delivery can put sobriety at risk.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner discuss final action on bills in Congress to address the opioid epidemic and fund federal health agencies. They also look at new efforts by the Food and Drug Administration to crack down on teen nicotine use.
A project that started in a Boston Veterans Affairs facility will soon go nationwide. It puts naloxone, also known as Narcan, into emergency supplies cabinets throughout the VA system.
In a Medicaid-funded pilot project starting with 19 counties, clinicians and other providers are now in charge of deciding what kind of treatment an offender needs. The change has rankled some judges and attorneys — and forced some felons to spend more time in jail — but it has been largely embraced by clinicians and county agencies.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Despite the growing epidemic of Americans misusing opioids and overdosing on the job, many employers turn a blind eye to addiction within their workforce — ill-equipped or unwilling to confront an issue they are at a loss to handle.
An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.
In this episode of KHN’s “What the Health?” Sarah Jane Tribble of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call talk about the Food and Drug Administration’s latest actions to address teenagers’ use of e-cigarettes, Arkansas’ Medicaid work requirements and news about the uninsured from the latest federal Census report.
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
Researchers combined the number of suicide deaths with those associated with drug overdoses in an effort to better grasp the overlap between these two public health epidemics.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico discuss Senate action on health funding and opioid legislation, the state of the individual insurance market and consternation over expiration dates on EpiPens, the self-injected allergy remedy. Also, could an otter with asthma signal a potential public health crisis?